CERE Annual Total Long Term Liabilities
$477.37 M
+$53.35 M+12.58%
31 December 2023
Summary:
As of February 5, 2025, CERE annual total long term liabilities is $477.37 million, with the most recent change of +$53.35 million (+12.58%) on December 31, 2023. During the last 3 years, it has risen by +$446.17 million (+1429.80%).CERE Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE Quarterly Long Term Liabilities
$478.78 M
+$1.41 M+0.30%
31 March 2024
Summary:
As of February 5, 2025, CERE quarterly total long term liabilities is $478.78 million, with the most recent change of +$1.41 million (+0.30%) on March 31, 2024. Over the past year, it has increased by +$8.62 million (+1.83%).CERE Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CERE Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.6% | +1.8% |
| 3 y3 years | +1429.8% | +675.5% |
| 5 y5 years | +1598.4% | +675.5% |
CERE Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | at high |
Cerevel Therapeutics Holdings Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $478.78 M(+0.3%) |
| Dec 2023 | $477.37 M(+12.6%) | $477.37 M(+1.5%) |
| Sept 2023 | - | $470.16 M(-1.7%) |
| June 2023 | - | $478.29 M(+9.8%) |
| Mar 2023 | - | $435.68 M(+2.7%) |
| Dec 2022 | $424.02 M | $424.02 M(-1.5%) |
| Sept 2022 | - | $430.33 M(+394.1%) |
| June 2022 | - | $87.10 M(+41.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $61.73 M(-8.7%) |
| Dec 2021 | $67.65 M(+116.8%) | $67.65 M(-8.1%) |
| Sept 2021 | - | $73.60 M(+8.5%) |
| June 2021 | - | $67.86 M(+100.1%) |
| Mar 2021 | - | $33.92 M(+8.7%) |
| Dec 2020 | $31.20 M(+11.0%) | $31.20 M(+496.4%) |
| Sept 2020 | - | $5.23 M |
| Dec 2019 | $28.11 M | - |
FAQ
- What is Cerevel Therapeutics Holdings annual total long term liabilities?
- What is the all time high annual total long term liabilities for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual total long term liabilities year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly long term liabilities year-on-year change?
What is Cerevel Therapeutics Holdings annual total long term liabilities?
The current annual total long term liabilities of CERE is $477.37 M
What is the all time high annual total long term liabilities for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual total long term liabilities is $477.37 M
What is Cerevel Therapeutics Holdings annual total long term liabilities year-on-year change?
Over the past year, CERE annual total long term liabilities has changed by +$53.35 M (+12.58%)
What is Cerevel Therapeutics Holdings quarterly total long term liabilities?
The current quarterly long term liabilities of CERE is $478.78 M
What is the all time high quarterly long term liabilities for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly total long term liabilities is $478.78 M
What is Cerevel Therapeutics Holdings quarterly long term liabilities year-on-year change?
Over the past year, CERE quarterly total long term liabilities has changed by +$8.62 M (+1.83%)